ARTICLE | Product Development

CHANT resonates

March 20, 2006 8:00 AM UTC

One of the first issues that doctors have when they encounter a stroke patient is determining what kind of stroke has occurred. The two main types, acute intracerebral hemorrhage and acute ischemic stroke, are distinguishable only via a CT scan. That's a problem for a couple of reasons. First, time is of the essence in stroke - it's generally accepted that the sooner a patient gets treatment, the better the chances for recovery. Second, it poses a problem for companies developing therapeutics for stroke, as the two types have completely different mechanisms.

Renovis Inc. and partner AstraZeneca plc are developing their NXY-059 for acute ischemic stroke, but in planning for a potential label, the companies are hoping their compound can be given without the need for a CT scan. ...